Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Dec;45(4):663-678.
doi: 10.1016/j.ogc.2018.07.007. Epub 2018 Oct 25.

Depression During and After the Perimenopause: Impact of Hormones, Genetics, and Environmental Determinants of Disease

Joyce T Bromberger  1 , Cynthia Neill Epperson  2
Affiliations
Review

Depression During and After the Perimenopause: Impact of Hormones, Genetics, and Environmental Determinants of Disease

Joyce T Bromberger et al. Obstet Gynecol Clin North Am. 2018 Dec.

Abstract

Vulnerability to depression is increased across the menopause transition and in the early years after the final menstrual period. Clinicians should systematically screen women in this age group; if depressive symptoms or disorder are present, treatment of depression should be initiated. Potential treatments include antidepressants for moderate to severe symptoms, psychotherapy to target psychological and interpersonal factors, and hormone therapy for women with first-onset major depressive disorder or elevated depressive symptoms and at low risk for adverse effects. Behavioral interventions can improve physical activity and sleep patterns.

Keywords: Depression; Genetics; Hormones; Perimenopause; Psychosocial and health factors.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Intersection of multiple risk factors for depression during the menopause transition (MT).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Kessler RC, McGonagle KA, Zhao S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994;51:8–19. - PubMed
    1. Hantsoo L, Epperson CN. Premenstrual Dysphoric Disorder: Epidemiology and Treatment. Curr Psychiatry Rep 2015;17:87. - PMC - PubMed
    1. Santoro N, Epperson CN, Mathews SB. Menopausal Symptoms and Their Management. Endocrinol Metab Clin North Am 2015;44:497–515. - PMC - PubMed
    1. Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 2004;61:62–70. - PubMed
    1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5 ed 2013.

Substances